David Lawrence
Directeur/Bestuurslid bij IOMAI CORPORATION
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Franck Grimaud | M | 58 |
Valneva Canada, Inc.
Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada.
Valneva Scotland Ltd.
Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers.
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014.
Valneva Sweden AB
Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers.
Valneva USA, Inc.
| 10 jaar |
Thomas Lingelbach | M | 60 |
Valneva Sweden AB
Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers.
Valneva Canada, Inc.
Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada.
Valneva USA, Inc.
Valneva Scotland Ltd.
Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers.
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | 18 jaar |
James Roger McIlroy | M | - |
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | 7 jaar |
Reinhard Kandera | M | 54 |
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | - |
Douglas Thomson | M | - |
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | - |
John A. Lambert | M | 71 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | 21 jaar |
James Ford | M | - | 29 jaar | |
Madhavan Nallani | M | - |
ACM Biolabs Pte Ltd.
ACM Biolabs Pte Ltd. BiotechnologyHealth Technology ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore. | 11 jaar |
Frédéric Jacotot | M | 60 |
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014.
Valneva Sweden AB
Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | 7 jaar |
Sally Jackson | F | - | 23 jaar | |
Neil MacGilp | M | - |
Ambicare Health Ltd.
Ambicare Health Ltd. Medical SpecialtiesHealth Technology Ambicare Health Ltd. manufactures medical products for skin care. The firm develops and commercializes proprietary, light emitting diode (LED) based devices for the treatment skin conditions and diseases. Its ambulatory lighting products offer solutions incorporating OLED (Organic Light Emitting Diode) and LED (Light Emitting Diode) technologies. The products offer battery operated flexible packaged solutions with high light uniformity. The company was founded by James Ferguson and Ifor Samuel in 2004 and is headquartered in Livingston, the United Kingdom. | 13 jaar |
Iain Baird | M | - |
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | - |
Wolfgang Bender | M | 70 |
Valneva Sweden AB
Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | 7 jaar |
Peter Moran | M | - |
ACM Biolabs Pte Ltd.
ACM Biolabs Pte Ltd. BiotechnologyHealth Technology ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore. | 9 jaar |
Erich Erber | M | - |
ACM Biolabs Pte Ltd.
ACM Biolabs Pte Ltd. BiotechnologyHealth Technology ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore. | - |
Lars Åke Gunnar Hallman | M | 82 |
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | 10 jaar |
Timothy Woodthorpe | M | - | 24 jaar | |
F. Weller Meyer | M | 81 | 18 jaar | |
David Redfern | M | 57 | 30 jaar | |
Richard Morgan | M | - |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | - |
Robert C. Seid | M | - | 16 jaar | |
Jin Sook Chung | F | - | 27 jaar | |
Kai Chen | M | - | - | |
Jenny Lee Harry | M | - |
ACM Biolabs Pte Ltd.
ACM Biolabs Pte Ltd. BiotechnologyHealth Technology ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore. | 2 jaar |
Mark R. Bamforth | M | 61 |
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | - |
Michael Watson | M | - |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 17 jaar |
Richard Douglas | M | 71 | 22 jaar | |
Thomas Martin Vernon | M | 85 | 18 jaar | |
Elmar Schnee | M | 65 |
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | 1 jaar |
Sarah A. Frech | M | - | - | |
Graham Rivers | M | - | 26 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Howard H. Pien | M | 66 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 15 jaar |
Christopher Viehbacher | M | 64 |
Glaxo Wellcome Plc
| 20 jaar |
Richard Sykes | M | 79 |
Glaxo Wellcome Plc
| 7 jaar |
Sean P. Lance | M | 77 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 6 jaar |
Julian Heslop | M | 70 |
Glaxo Wellcome Plc
| 13 jaar |
Jack Goldstein | M | 77 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 4 jaar |
Ursula B. Bartels | F | 66 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 14 jaar |
Karl Hård | M | 62 | 1 jaar | |
William Louv | M | - | 21 jaar | |
Robert J. DiVasto | M | 68 |
Glaxo Wellcome Plc
| 12 jaar |
Phillip John Tottey | M | 62 | 3 jaar | |
Alex Howarth | M | 55 | 10 jaar | |
Thomas P. Monath | M | 83 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 14 jaar |
Iain Ross | M | 71 | 4 jaar | |
Michèle Barzach | M | - | 7 jaar | |
John David Coombe | M | 79 | 5 jaar | |
Murray Stewart | M | 63 | 17 jaar | |
Ian Maurice Gray Prosser | M | 81 | 9 jaar | |
Robert Carr | M | - | 26 jaar | |
Jean-Pierre Garnier | M | 75 | 8 jaar | |
Robert Alexander Ingram | M | 81 |
Glaxo Wellcome Plc
| 14 jaar |
Tim Tyson | M | 71 |
Glaxo Wellcome Plc
| 10 jaar |
James A. Nash | M | 73 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 2 jaar |
Peter Traber | M | 69 | 3 jaar | |
Ted G. Wood | M | 86 | 16 jaar | |
Nick Hirons | M | - | - | |
Denis Brodsky | M | 53 | 5 jaar | |
Michael Owen | M | 73 | 9 jaar | |
Thierry Loriot | M | - | - | |
John Lepore | M | - | 15 jaar | |
Gregg Brandyberry | M | - | 16 jaar | |
James Wu | M | - | 10 jaar | |
Michael Allen Luther | M | 67 | 15 jaar | |
Lisa Bright | F | 56 | 17 jaar | |
Dean Hakanson | M | 72 | 7 jaar | |
Dean Mitchell | M | 68 | 15 jaar | |
John Apeler Keller | M | 60 | - | |
Brian Blakey | M | 61 | 6 jaar | |
Roger L. Hawley | M | 71 | 14 jaar | |
Steve Damment | M | - | 17 jaar | |
Jon Ellis | M | 57 | 21 jaar | |
Melissa Beelen | F | - | 12 jaar | |
Clare Khan | M | 72 | 11 jaar | |
Lisa Trivison Beck | F | 62 | 24 jaar | |
Ian Pitfield | M | 58 | 23 jaar | |
Phil Thomson | M | - |
Glaxo Wellcome Plc
| 5 jaar |
Neil Pegg | M | - | - | |
Carol Ashe | F | 66 | 13 jaar | |
Lisa Porter | M | 60 | 5 jaar | |
Paul W. Hawran | M | 71 | 9 jaar | |
Michael D. Rogers | M | 68 | 6 jaar | |
Eric Carter | M | 72 | - | |
Peter Goodfellow | M | 72 | 8 jaar | |
J. Michael Hamilton | M | 75 | 5 jaar | |
Faheem Hasnain | M | 65 | 14 jaar | |
Kristi L. Meints | F | 69 | 18 jaar | |
Don Soland | M | 65 | 9 jaar | |
Margaret Dalesandro | M | 77 | 2 jaar | |
Duncan Learmouth | M | - | - | |
James R. Beery | M | 83 | 1 jaar | |
Peter Strong | M | - | 3 jaar | |
Douglas B. Snyder | M | 60 | 6 jaar | |
Dimitri Dimitriou | M | - | 5 jaar | |
Robert Ruffolo | M | 74 | 16 jaar | |
Lieven Nuyttens | M | 57 | 6 jaar | |
Anthony S. Murabito | M | - | 19 jaar | |
Steven Gelone | M | 56 | 2 jaar | |
Ronaldo Hermann Schmitz | M | 85 | 9 jaar | |
Ford Calhoun | M | - | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigd Koninkrijk | 82 | 82.00% |
Verenigde Staten | 15 | 15.00% |
Zweden | 6 | 6.00% |
Singapore | 4 | 4.00% |
Canada | 2 | 2.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- David Lawrence
- Persoonlijk netwerk